Skip to main content

Table 4 Echocardiographic features of group 1 and group 3 participants

From: Assessment of myocardial work in sarcomere gene mutation carriers, healthy controls and overt nonobstructive hypertrophic cardiomyopathy

 

G1: Carriers

n = 51

G3: Controls

n = 32

p-value

Transthoracic echocardiogram

EDLVD, mm, median (IQ)

44.00 (8.00)

51.50 (7.80)

< 0.001

ESLVD, mm, mean (SD)

28.66 (4.36)

33.25 (4.47)

< 0.001

LA area, cm², mean (SD)

17.72 (4.33)

18.56 (3.51)

0.360

2D LVEF, %, mean (SD)

59.76 (5.11)

58.81 (3.69)

0.960

E/e’, median (IQ)

5.86 (2.00)

5.68 (2.00)

0.244

Blood pressure

   

Systolic arterial BP, mmHg, median (IQ)

115.00 (20.00)

123.00 (26.00)

0.09

Diastolic arterial BP, mmHg, median (IQ)

70.00 (12.00)

74.50 (14.00)

0.101

Myocardial deformation analysis

   

GWI, mmHg%, median (IQ)

1695.00 (332.00)

1881.50 (490.00)

0.001

GCW, mmHg%, mean (SD)

2017.78 (323.05)

2329.31 (485.44)

0.002

GWW, mmHg%, median (IQ)

96.00 (69.00)

81.50 (43.00)

0.457

GWE, %, median (IQ)

95.00 (3.00)

96.00 (2.00)

0.177

GLS, %, median (IQ)

-18.00 (3.00)

-18.45 (2.60)

0.256

  1. BP: Blood pressure; EDLVD: end-diastolic left ventricular diameter; ESLVD: end-systolic left ventricular diameter; IQ: interquartile range; GWI: Global work index; GCW: Global constructive work; GWW: Global wasted work; GWE: Global work efficiency; GLS: Global longitudinal strain; LA: Left atrium; LVEF: left ventricle ejection fraction, SD: standard deviation